A Q&A On CMC In mRNA Manufacturing

The level of audience engagement during our BioProcess Online Live event CMC, SCALE UP, & THE ROAD TO mRNA REGULATORY APPROVAL was so remarkable, panelists Akhilesh Bhambhani, Sr. Director, Biologics Drug Product Development at Ultragenyx Pharmaceuticals and Roberta Duncan, VP and mRNA Program Lead at Seqirus agreed to stick around for an extra 25 minutes to answer audience questions. In this segment of the event, we address a rapid cadence of questions on CMC considerations for mRNA developers.